Free Trial

Carisma Therapeutics (CARM) Earnings Date, Estimates & Call Transcripts

Carisma Therapeutics logo
$0.82 -0.03 (-3.52%)
(As of 11/22/2024 ET)

Carisma Therapeutics Latest Earnings Summary

Upcoming Q4
Earnings Date
Apr. 7Estimated
Actual EPS
(Nov. 7)
-$0.31
Consensus EPS
(Nov. 7)
-$0.31

Carisma Therapeutics announced Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.31, which hit the consensus estimate of -$0.31. Quarterly revenue was reported to be $3.39 million. With a trailing EPS of -$1.56, Carisma Therapeutics' earnings are expected to grow next year, from ($1.33) to ($1.26) per share.

CARM Upcoming Earnings

Carisma Therapeutics' next earnings date is estimated for Monday, April 7, 2025, based off prior year's reporting schedules.

Get Carisma Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Carisma Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CARM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CARM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Carisma Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.47-$0.26-$0.37
Q2 20242-$0.45-$0.27-$0.36
Q3 20242-$0.43-$0.29-$0.36
Q4 20242-$0.47-$0.26-$0.37
FY 20248-$1.82-$1.08-$1.45
Q1 20251-$0.48-$0.48-$0.48
Q2 20251-$0.50-$0.50-$0.50
Q3 20251-$0.54-$0.54-$0.54
Q4 20251-$0.56-$0.56-$0.56
FY 20254($2.08)($2.08)($2.08)

Carisma Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
4/7/2025
(Estimated)
------- 
11/7/2024Q3 2024-$0.31-$0.31--$0.31-$3.39M
8/8/2024--$0.36-$0.27+$0.09-$0.27$3.65M$9.20M
5/9/2024Q1 2024-$0.37-$0.46 -$0.09-$0.46$3.90M$3.40M  
4/1/2024Q4 2023--$0.52 -$0.52-$0.52$4.00M$4.29M
11/9/2023Q3 2023-$0.60-$0.53+$0.07-$0.53-$3.83M
8/10/2023Q2 2023-$0.66-$0.49+$0.17-$0.49-$3.56M
5/11/2023Q1 2023--$1.93 -$1.93-$1.93-$3.24M
2/28/2023Q4 2022-$2.20-$0.80+$1.40-$0.80--

Carisma Therapeutics Earnings - Frequently Asked Questions

Carisma Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based off last year's report dates. Learn more on CARM's earnings history.

In the previous quarter, Carisma Therapeutics (NASDAQ:CARM) reported ($0.31) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.31). Learn more on analysts' earnings estimate vs. CARM's actual earnings.

Carisma Therapeutics (NASDAQ:CARM) has a recorded annual revenue of $14.92 million.

Carisma Therapeutics (NASDAQ:CARM) has a recorded net income of -$86.88 million. CARM has generated -$1.56 earnings per share over the last four quarters.

Carisma Therapeutics's earnings are expected to grow from ($1.33) per share to ($1.26) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CARM) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners